CARBOPROST TROMETHAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Carboprost Tromethamine patents expire, and when can generic versions of Carboprost Tromethamine launch?
Carboprost Tromethamine is a drug marketed by Alembic, Amneal, Ani Pharms, Caplin, Dr Reddys, Eugia Pharma, Gland Pharma Ltd, Long Grove Pharms, Micro Labs, Sola Pharms, Steriscience Speclts, and Sunny. and is included in twelve NDAs.
The generic ingredient in CARBOPROST TROMETHAMINE is carboprost tromethamine. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the carboprost tromethamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Carboprost Tromethamine
A generic version of CARBOPROST TROMETHAMINE was approved as carboprost tromethamine by DR REDDYS on July 2nd, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARBOPROST TROMETHAMINE?
- What are the global sales for CARBOPROST TROMETHAMINE?
- What is Average Wholesale Price for CARBOPROST TROMETHAMINE?
Summary for CARBOPROST TROMETHAMINE
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 17 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| Clinical Trials: | 3 |
| Patent Applications: | 228 |
| DailyMed Link: | CARBOPROST TROMETHAMINE at DailyMed |
Recent Clinical Trials for CARBOPROST TROMETHAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Northwestern University | Early Phase 1 |
| C.R.Darnall Army Medical Center | N/A |
| American University of Beirut Medical Center | N/A |
Pharmacology for CARBOPROST TROMETHAMINE
| Drug Class | Prostaglandin Analog |
Medical Subject Heading (MeSH) Categories for CARBOPROST TROMETHAMINE
Anatomical Therapeutic Chemical (ATC) Classes for CARBOPROST TROMETHAMINE
US Patents and Regulatory Information for CARBOPROST TROMETHAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 217198-001 | Jun 15, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Gland Pharma Ltd | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 217657-001 | Aug 7, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Caplin | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 216882-001 | Feb 13, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sunny | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 213118-001 | Mar 25, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Long Grove Pharms | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 214499-001 | Aug 9, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Amneal | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 215337-001 | Jan 27, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ani Pharms | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 215901-001 | Jan 25, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
